Type 1 Diabetes carries high burden for affected youth and their families. Advances in insulin therapy and technology have been associated with increased obesity with 1/3 adolescents being overweight/obese. Since obesity runs in families and carries risk for poor outcomes psychologically and medically, the investigators are adapting our successful evidence-based Family Based Treatment for hybrid delivery to improve obesity and metabolic control in the affected youth and improve obesity and related co-morbidities in their parents.
No linked publications found in PubMed
Inclusion Criteria: * T1D of 12 or more months duration * Age 6-17-years * Presence of overweight/obesity * Youth uses a pump for insulin delivery and a continuous glucose monitoring device to monitor glycemic levels * Youth has one parent with overweight/obesity willing to participate in the program Exclusion Criteria: * Child: * Chronic conditions other than T1D * Other autoimmune conditions other then T1D or autoimmune thyroiditis. * Medications that can affects weight, such as medications used to treat Attention Deficit Disorder or high dose steroids used to treat asthma. * Depression symptoms by standard of care Patient Health Questionnaire (PHQ) 9 in the child or parent * Inability to perform at least mild physical activity such as walking * Child with handicap (such as developmental delay or deafness) that would prevent him/her from benefitting from counseling in person and/or remotely Participating parent with * symptoms of depression assessed by standard of care PHQ * autoimmune disorders other than T1D or autoimmune thyroiditis * Participating parents with chronic disorder that is treated with medications that interfere with weight loss or are preventing him/her from performing at least mild physical activity